Circulation of Pneumocystis dihydropteroate synthase mutants in France

Diagnostic Microbiology and Infectious Disease

Volumn 74, Issue 2, 2012, Pages 119-124

  Le Gal, Solène ^a,b   Damiani, Céline ^c,d   Perrot, Maëla ^a   Rouillé, Amélie ^b   Virmaux, Michèle ^a   Quinio, Dorothée ^a,b   Moalic, Elodie ^a,b   Saliou, Philippe ^b   Berthou, Christian ^b,e   Le Meur, Yann ^b,e   Totet, Anne ^c,d   Nevez, Gilles ^a,b  

^a UNIVERSITÉ DE BREST   (France)

^b BREST UNIVERSITY HOSPITAL   (France)

^c AMIENS UNIVERSITY HOSPITAL   (France)

^d UNIVERSITÉ DE PICARDIE JULES VERNE   (France)

^e Universite de Brest   (France)

Author keywords

DHPS; Mutants; Pneumocystis jirovecii

Indexed keywords

ALANINE; DIHYDROPTEROATE SYNTHASE; PROLINE; SERINE; THREONINE;

AMINO ACID SUBSTITUTION; ARTICLE; CONTROLLED STUDY; DEMOGRAPHY; FRANCE; FUNGUS IDENTIFICATION; FUNGUS MUTANT; GENE LOCUS; GEOGRAPHY; MEDICAL RECORD REVIEW; NONHUMAN; PNEUMOCYSTIS JIROVECI; POLYMERASE CHAIN REACTION; PREDICTION; PREVALENCE; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; TRAVEL; WILD TYPE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; DIHYDROPTEROATE SYNTHASE; FEMALE; FRANCE; HUMANS; MALE; MIDDLE AGED; MOLECULAR EPIDEMIOLOGY; MOLECULAR TYPING; MUTANT PROTEINS; PNEUMOCYSTIS JIROVECII; PNEUMONIA, PNEUMOCYSTIS; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 84866180667     PISSN: 07328893     EISSN: 18790070     Source Type: Journal    
DOI: 10.1016/j.diagmicrobio.2012.06.002     Document Type: Article

References (40)

1. Alvarez-Martinez M.J., Miro J.M., Valls M.E., Mas J., de la Bellacasa J.P., Sued O., et al. Prevalence of dihydropteroate synthase genotypes before and after the introduction of combined antiretroviral therapy and their influence on the outcome of Pneumocystis pneumonia in HIV-1-infected patients. Diagn Microbiol Infect Dis 2010, 68:60-65.
2. Armstrong W., Meshnick S., Kazanjian P. Pneumocystis carinii mutations associated with sulfa and sulfone prophylaxis failures in immunocompromised patients. Microbes Infect 2000, 2:61-67.
3. Beard C.B., Carter J.L., Keely S.P., Huang L., Pieniazek N.J., Moura I.N., et al. Genetic variation in Pneumocystis carinii isolates from different geographic regions: implications for transmission. Emerg Infect Dis 2000, 6:265-272.
4. Beser J., Dini L., Botero-Kleiven S., Krabbe M., Lindh J., Hagblom P. Absence of dihydropteroate synthase gene mutations in Pneumocystis jirovecii isolated from Swedish patients. Med Mycol 2012, 50:320-323.
5. Cazein F., Lot F., Pillonel J., Pinget R., Bousquet V., Le Strat Y., et al. Surveillance de l'infection à VIH-sida en France, 2009. Bull Epidémiol Hebd 2010, 45-46:467-472.
6. Choukri F., Menotti J., Sarfati C., Lucet J.C., Nevez G., Garin Y.J., et al. Quantification and spread of Pneumocystis jirovecii in the surrounding air of patients with Pneumocystis pneumonia. Clin Infect Dis 2010, 51:259-265.
7. Cohen-Bacrie S., Ben Kahla I., Botelho-Nevers E., Million M., Parola P., Brouqui P., et al. Imported extensively drug-resistant Mycobacterium tuberculosis Beijing genotype, Marseilles, France Euro Surveill 2011;16(16): pii=19846. Available online:. http://www.eurosurveillance.org/ViewArticle.aspx?ArticleID=19846.
8. Costa M.C., Helweg-Larsen J., Lundgren B., Antunes F., Matos O. Mutations in the dihydropteroate synthase gene of Pneumocystis jiroveci isolates from Portuguese patients with Pneumocystis pneumonia. Int J Antimicrob Agents 2003, 22:516-520.
9. Crothers K., Beard C.B., Turner J., Groner G., Fox M., Morris A., et al. Severity and outcome of HIV-associated Pneumocystis pneumonia containing Pneumocystis jirovecii dihydropteroate synthase gene mutations. AIDS 2005, 19:801-805.
10. Demanche C., Berthelemy M., Petit T., Polack B., Wakefield A.E., Dei-Cas E., et al. Phylogeny of Pneumocystis carinii from 18 primate species confirms host specificity and suggests coevolution. J Clin Microbiol 2001, 39:2126-2133.
11. Diop-Santos L., Lacube P., Latouche S., Kac G., Mayaud C., Marteau M., et al. Contribution of dihydropteroate synthase gene typing for Pneumocystis carinii f.sp. hominis epidemiology. J Eukaryot Microbiol 1999, 46:133S-134S.
12. Esteves F., Montes-Cano M.A., de la Horra C., Costa M.C., Calderon E.J., Antunes F., et al. Pneumocystis jirovecii multilocus genotyping profiles in patients from Portugal and Spain. Clin Microbiol Infect 2008, 14:356-362.
13. European Centre for Disease Prevention and Control/WHO Regional Office for Europe HIV/AIDS surveillance in Europe 2009 2010, European Center for Disease Prevention and Control, Stockholm.
14. Hauser P.M., Nahimana A., Taffe P., Weber R., Francioli P., Bille J., et al. Interhuman transmission as a potential key parameter for geographical variation in the prevalence of Pneumocystis jirovecii dihydropteroate synthase mutations. Clin Infect Dis 2010, 51:e28-e33.
15. Helweg-Larsen J. Pneumocystis jiroveci. Applied molecular microbiology, epidemiology and diagnosis. Dan Med Bull 2004, 51:251-273.
16. Helweg-Larsen J., Benfield T.L., Eugen-Olsen J., Lundgren J.D., Lundgren B. Effects of mutations in Pneumocystis carinii dihydropteroate synthase gene on outcome of AIDS-associated P. carinii pneumonia. Lancet 1999, 354:1347-1351.
17. Huang L., Beard C.B., Creasman J., Levy D., Duchin J.S., Lee S., et al. Sulfa or sulfone prophylaxis and geographic region predict mutations in the Pneumocystis carinii dihydropteroate synthase gene. J Infect Dis 2000, 182:1192-1198.
18. Kazanjian P., Armstrong W., Hossler P.A., Burman W., Richardson J., Lee C.H., et al. Pneumocystis carinii mutations are associated with duration of sulfa or sulfone prophylaxis exposure in AIDS patients. J Infect Dis 2000, 182:551-557.
19. Kazanjian P., Locke A.B., Hossler P.A., Lane B.R., Bartlett M.S., Smith J.W., et al. Pneumocystis carinii mutations associated with sulfa and sulfone prophylaxis failures in AIDS patients. AIDS 1998, 12:873-878.
20. Lane B.R., Ast J.C., Hossler P.A., Mindell D.P., Bartlett M.S., Smith J.W., et al. Dihydropteroate synthase polymorphisms in Pneumocystis carinii. J Infect Dis 1997, 175:482-485.
21. Le Gal S., Damiani C., Rouille A., Grall A., Treguer L., Virmaux M., et al. A cluster of Pneumocystis infections among renal transplant recipients: molecular evidence of colonized patients as potential infectious sources of Pneumocystis jirovecii. Clin Infect Dis 2012, 54:e62-e71.
22. Ma L., Kovacs J.A., Cargnel A., Valerio A., Fantoni G., Atzori C. Mutations in the dihydropteroate synthase gene of human-derived Pneumocystis carinii isolates from Italy are infrequent but correlate with prior sulfa prophylaxis. J Infect Dis 2002, 185:1530-1532.
23. Magne D., Angoulvant A., Botterel F., Bouges-Michel C., Bougnoux M.E., Bouree P., et al. Pneumocystosis: a network survey in the Paris area 2003-2008. Eur J Clin Microbiol Infect Dis 2011, 30:673-675.
24. Matos O., Esteves F. Epidemiology and clinical relevance of Pneumocystis jirovecii Frenkel, 1976 dihydropteroate synthase gene mutations. Parasite 2010, 17:219-232.
25. Mei Q., Gurunathan S., Masur H., Kovacs J.A. Failure of co-trimoxazole in Pneumocystis carinii infection and mutations in dihydropteroate synthase gene. Lancet 1998, 351:1631-1632.
26. Meliani L., Develoux M., Marteau-Miltgen M., Magne D., Barbu V., Poirot J.L., et al. Real time quantitative PCR assay for Pneumocystis jirovecii detection. J Eukaryot Microbiol 2003, 50(Suppl):651.
27. Miller R.F., Lindley A.R., Ambrose H.E., Malin A.S., Wakefield A.E. Genotypes of Pneumocystis jiroveci isolates obtained in Harare, Zimbabwe, and London, United Kingdom. Antimicrob Agents Chemother 2003, 47:3979-3981.
28. Montes-Cano M.A., de la Horra C., Martin-Juan J., Varela J.M., Torronteras R., Respaldiza N., et al. Pneumocystis jiroveci genotypes in the Spanish population. Clin Infect Dis 2004, 39:123-128.
29. Morris A., Wei K., Afshar K., Huang L. Epidemiology and clinical significance of Pneumocystis colonization. J Infect Dis 2008, 197:10-17.
30. Nahimana A., Rabodonirina M., Zanetti G., Meneau I., Francioli P., Bille J., et al. Association between a specific Pneumocystis jiroveci dihydropteroate synthase mutation and failure of pyrimethamine/sulfadoxine prophylaxis in human immunodeficiency virus-positive and -negative patients. J Infect Dis 2003, 188:1017-1023.
31. Nevez G., Raccurt C., Jounieaux V., Dei-Cas E., Mazars E. Pneumocystosis versus pulmonary Pneumocystis carinii colonization in HIV-negative and HIV-positive patients. AIDS 1999, 13:535-536.
32. Nevez G., Totet A., Jounieaux V., Schmit J.L., Dei-Cas E., Raccurt C. Pneumocystis jiroveci internal transcribed spacer types in patients colonized by the fungus and in patients with pneumocystosis from the same French geographic region. J Clin Microbiol 2003, 41:181-186.
33. Rabodonirina M., Vanhems P., Couray-Targe S., Gillibert R.P., Ganne C., Nizard N., et al. Molecular evidence of interhuman transmission of Pneumocystis pneumonia among renal transplant recipients hospitalized with HIV-infected patients. Emerg Infect Dis 2004, 10:1766-1773.
34. Stringer J.R., Beard C.B., Miller R.F., Wakefield A.E. A new name (Pneumocystis jiroveci) for Pneumocystis from humans. Emerg Infect Dis 2002, 8:891-896.
35. Totet A., Latouche S., Lacube P., Pautard J.C., Jounieaux V., Raccurt C., et al. Pneumocystis jirovecii dihydropteroate synthase genotypes in immunocompetent infants and immunosuppressed adults, Amiens, France. Emerg Infect Dis 2004, 10:667-673.
36. Totet A., Meliani L., Lacube P., Pautard J.C., Raccurt C., Roux P., et al. Immunocompetent infants as a human reservoir for Pneumocystis jirovecii: rapid screening by non-invasive sampling and real-time PCR at the mitochondrial large subunit rRNA gene. J Eukaryot Microbiol 2003, 50(Suppl):668-669.
37. Valerio A., Tronconi E., Mazza F., Fantoni G., Atzori C., Tartarone F., et al. Genotyping of Pneumocystis jiroveci pneumonia in Italian AIDS patients. Clinical outcome is influenced by dihydropteroate synthase and not by internal transcribed spacer genotype. J Acquir Immune Defic Syndr 2007, 45:521-528.
38. Visconti E., Ortona E., Mencarini P., Margutti P., Marinaci S., Zolfo M., et al. Mutations in dihydropteroate synthase gene of Pneumocystis carinii in HIV patients with Pneumocystis carinii pneumonia. Int J Antimicrob Agents 2001, 18:547-551.
39. Volpe F., Dyer M., Scaife J.G., Darby G., Stammers D.K., Delves C.J. The multifunctional folic acid synthesis fas gene of Pneumocystis carinii appears to encode dihydropteroate synthase and hydroxymethyldihydropterin pyrophosphokinase. Gene 1992, 112:213-218.
40. Walzer P.D., Cushion M.T. Pneumocystis pneumonia 2005, Marcel Dekker, New York.